Navigation

Clinical audit

NICE produces clinical audit tools for local clinical audit to improve care, containing clinical audit standards based on NICE guidance.

The most recent documents are Excel based and also contain:

  • a data collection sheet
  • a clinical audit report that provides basic information about the audit and automatically displays the audit results
  • an action plan template
  • an appendix containing a printable data collection form.

Previous versions of the Clinical audit tools produced by NICE to accompany guidance were called Audit support or Audit criteria.

Access all the clinical audit documents from the list below. The most recent clinical audit tools can be found at the bottom of the list.

For quick access to some recent examples of the clinical audit tools we produce, please follow the links below:

Clinical audit tools for CG156 Fertility

Clinical audit tools for CG157 Hyperphosphataemia in chronic kidney disease

Clinical audit tool for CG158 Conduct disorders in children and young people

Tell us what you think

We want to hear what you think of clinical audit and your experiences of using them.

Details of some of the work we have done to improve our audit tools can be found in the NICE clinical audit survey report 2011.

External Reference Group

If you are a clinical audit specialist or healthcare professional who would be prepared to help us review the clinical audit tools, please apply to join our 'Audit Panel'.

Results 161-180 of 370

Ref Title Setting
CG80 Breast cancer (early & locally advanced): audit support General
TA170 Venous thromboembolism - rivaroxaban: audit support
IPG329 Total prosthetic replacement of the temporomandibular joint: audit support
CG83 Critical illness rehabilitation: audit support
IPG321 Lateral (including extreme, extra and direct lateral) interbody fusion in the lumbar spine: audit support
TA169 Renal cell carcinoma - sunitinib: audit criteria
CG85 Glaucoma: audit support
IPG324 Electrocautery cutting balloon treatment for pelviureteric junction obstruction: audit support
IPG330 Vagus nerve stimulation for treatment-resistant depression: audit support
IPG360 Endoscopic submucosal dissection of gastric lesions: audit support General
IPG335 Endoscopic submucosal dissection of lower gastrointestinal lesions: audit support
IPG335 Endoscopic submucosal dissection of lower gastrointestinal lesions: electronic clinical audit tool General
CG87 Type 2 diabetes - newer agents (a partial update of CG66): audit support General
CG86 Coeliac disease: audit support
TA172 Head and neck cancer (squamous cell carcinoma) - cetuximab: audit support
CG89 When to suspect child maltreatment: audit support
TA173 Hepatitis B - tenofovir disoproxil fumarate: audit support
IPG332 Surgical correction of hallux valgus using minimal access techniques: audit support
IPG340 Macular translocation with 360 retinotomy for wet age related macular degeneration: audit support
TA176 Colorectal cancer (first line) - cetuximab: biological agents for metastatic colorectal cancer - clinical audit tool General

This page was last updated: 05 June 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.